[ad_1]
RIYADH: Saudi Arabia unveiled details of a major campaign to eradicate hepatitis C by joining the World Health Organization (WHO) to celebrate World Hepatitis Day on July 28th.
Global awareness of hepatitis and encourages prevention, diagnosis and treatment to eradicate the serious health problems caused by the disease.
The Saudi Ministry of Health plans to treat 10,000 patients each year to eradicate hepatitis C by 2030.
The infectious disease is caused by a virus that primarily affects the liver.
During the initial infection, people often have mild symptoms or none. However, without treatment, the virus can cause liver failure, cancer or even death.
The Department of Health and AbbVie, a global biopharmaceutical company, Wednesday renewed their partnership in the fight against the hepatitis C virus.
2016, Etmaen, a campaign to raise public awareness about Hepatitis C, was launched in 10 cities of the Kingdom
The next phase of the initiative will focus on education, screening, diagnosis and treatment
. Abdullah Assiri, Assistant Deputy Minister for Preventive Health, said: "Our efforts are aimed at continuing to improve the current standards of care in the Kingdom, in line with our goal of eliminating the virus from the disease. here 2030. "
his efforts to discover undiagnosed cases in the community and then refer patients to treatment.
"The Ministry of Health is committed to tracking 100,000 people in 2018," said the minister.
"The Ministry has The number of hospitals and health centers specializing in the treatment of hepatitis C, as well as the number of doctors, allows us to have realistic goals to deal with 10,000 patients a year, "he said.
Ministry of Health Expands Treatment to 48 Primary Health Care Centers Across the Kingdom.
AbbVie Will Start Campaign to Educate Physicians of primary care on the diagnosis and treatment of hepatitis C. It will also support the Ministry of Health.The company organizes screening sessions in primary health care centers throughout the Kingdom, in using a painless and non-invasive test to evaluate the stage of liver disease in patients
partnership, Rami Fayed, regional vice president for the Middle East and Africa of AbbVie, has stated: "We are committed to supporting the Ministry Health in its efforts to make a remarkable impact on NTS lives in Saudi Arabia. "
According to the WHO, viral hepatitis B and C are major health problems, affecting 325 million people worldwide and resulting in 1.34 million deaths each year.
At least 60% cases of liver cancer are due to late testing and treatment of viral hepatitis B and C.
The low coverage of tests and treatments is the main gap to be met in order to achieve the global elimination goals. from here 2030.
Source link
